Published in Blood on September 03, 2013
Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood (2015) 1.60
Global loss of DNA methylation uncovers intronic enhancers in genes showing expression changes. Genome Biol (2014) 1.12
Ikaros fingers on lymphocyte differentiation. Int J Hematol (2014) 0.94
Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production. J Immunol (2014) 0.87
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. Leukemia (2015) 0.80
Ikaros: the enhancer makes the difference. Blood (2013) 0.80
Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation. Nat Genet (2015) 0.79
Variations in mRNA and protein levels of Ikaros family members in pediatric T cell acute lymphoblastic leukemia. Ann Transl Med (2016) 0.75
An Ikaros Promoter Element with Dual Epigenetic and Transcriptional Activities. PLoS One (2015) 0.75
The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma. Genes Dev (2017) 0.75
Age-associated DNA methylation changes in naive CD4(+) T cells suggest an evolving autoimmune epigenotype in aging T cells. Epigenomics (2017) 0.75
Case report: Exome sequencing identifies T-ALL with myeloid features as a IKZF1-struck early precursor T-cell malignancy. Leuk Res Rep (2017) 0.75
Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia. Oncol Lett (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68
A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol (2011) 16.53
Widespread transcription at neuronal activity-regulated enhancers. Nature (2010) 16.52
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell (2005) 8.37
A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol (2010) 6.01
The Ikaros gene is required for the development of all lymphoid lineages. Cell (1994) 5.90
A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell (1995) 4.02
Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity (2009) 3.18
Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol (2006) 2.82
Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol (2011) 2.79
Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science (1992) 2.77
H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J (2011) 2.38
Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity (1999) 2.19
Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol (1998) 1.92
Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nat Immunol (2011) 1.89
Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J Exp Med (1999) 1.82
Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol Cell (2012) 1.71
A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Blood (2013) 1.69
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL. Blood (2010) 1.60
Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med (2006) 1.49
T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci U S A (2011) 1.41
Ikaros confers early temporal competence to mouse retinal progenitor cells. Neuron (2008) 1.36
Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity (2010) 1.35
Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia. Am J Blood Res (2013) 1.33
Ikaros-family proteins: in search of molecular functions during lymphocyte development. Curr Top Microbiol Immunol (2005) 1.16
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. PLoS One (2012) 1.15
Transcription factors required for lymphoid lineage commitment. Curr Opin Immunol (1997) 1.13
A complex network of regulatory elements in Ikaros and their activity during hemo-lymphopoiesis. EMBO J (2003) 1.07
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia (2012) 1.07
Acute lymphoblastic leukemia--on the wings of IKAROS. N Engl J Med (2009) 0.91
Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neurons. J Comp Neurol (2010) 0.89
Ikaros is expressed in developing striatal neurons and involved in enkephalinergic differentiation. J Neurochem (2007) 0.89
The lambda5-VpreB1 locus--a model system for studying gene regulation during early B cell development. Semin Immunol (2005) 0.84
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell (2007) 7.99
High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science (2010) 5.91
Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis (2013) 4.27
Subtle variations in Pten dose determine cancer susceptibility. Nat Genet (2010) 4.19
Distinct stem cell populations regenerate the follicle and interfollicular epidermis. Dev Cell (2005) 3.98
Sex-specific parent-of-origin allelic expression in the mouse brain. Science (2010) 3.89
SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell (2011) 3.71
Spatial organization of the flow of genetic information in bacteria. Nature (2010) 3.43
Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity (2009) 3.18
Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol (2006) 2.82
Epidermal stem cells arise from the hair follicle after wounding. FASEB J (2007) 2.81
Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity (2007) 2.65
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med (2012) 2.62
beta-catenin activity in the dermal papilla regulates morphogenesis and regeneration of hair. Dev Cell (2010) 2.60
The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. Immunity (2004) 2.54
Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat Immunol (2012) 2.49
T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res (2009) 2.43
Modeling recent human evolution in mice by expression of a selected EDAR variant. Cell (2013) 2.17
TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A (2009) 2.13
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02
Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential. Nat Immunol (2003) 1.97
The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med (2010) 1.93
Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. J Immunol (2007) 1.88
A critical role for the cytoplasmic tail of pTalpha in T lymphocyte development. Nat Immunol (2002) 1.88
The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation. Genes Dev (2008) 1.82
The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell (2002) 1.79
Thymic selection revisited: how essential is it? Immunol Rev (2003) 1.71
A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Blood (2013) 1.69
The serine protease Corin is a novel modifier of the Agouti pathway. Development (2007) 1.69
Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat Immunol (2005) 1.66
Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition. Mol Cell Biol (2004) 1.53
Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc Natl Acad Sci U S A (2009) 1.50
Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med (2008) 1.49
Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation. Blood (2007) 1.48
Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol (2009) 1.48
A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Cancer Res (2009) 1.48
Ikaros SUMOylation: switching out of repression. Mol Cell Biol (2005) 1.48
Stochastic expression of the interferon-β gene. PLoS Biol (2012) 1.47
Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: a retrospective study. Ear Nose Throat J (2011) 1.45
Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2beta determine silencer activity and Cd4 gene expression. Immunity (2007) 1.45
Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A (2002) 1.44
Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development (2006) 1.44
Aiolos is required for the generation of high affinity bone marrow plasma cells responsible for long-term immunity. J Exp Med (2004) 1.44
The significant role of mast cells in cancer. Cancer Metastasis Rev (2011) 1.42
T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci U S A (2011) 1.41
Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. Genes Dev (2008) 1.41
Dermal papilla cell number specifies hair size, shape and cycling and its reduction causes follicular decline. Development (2013) 1.41
c-Myc mediates pre-TCR-induced proliferation but not developmental progression. Blood (2006) 1.39
Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog (2007) 1.38
Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice. J Immunol (2003) 1.36
Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity (2010) 1.35
Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A (2012) 1.30
Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med (2006) 1.29
Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes. J Immunol (2002) 1.28
Pre-TCRalpha and TCRalpha are not interchangeable partners of TCRbeta during T lymphocyte development. J Exp Med (2004) 1.28
Stable inheritance of telomere chromatin structure and function in the absence of telomeric repeats. Genes Dev (2003) 1.27
Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice. Exp Hematol (2007) 1.26
Unconventional potentiation of gene expression by Ikaros. J Biol Chem (2002) 1.25
Wnt signaling through the beta-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells. J Invest Dermatol (2004) 1.24
Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet (2013) 1.23
On the brink of becoming a T cell. Curr Opin Immunol (2002) 1.21
The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development (2007) 1.21
Beta-catenin activity in the dermal papilla of the hair follicle regulates pigment-type switching. Proc Natl Acad Sci U S A (2010) 1.19
Ikaros and chromatin regulation in early hematopoiesis. Curr Opin Immunol (2007) 1.18
Immediate hypersensitivity reaction associated with the rapid infusion of Crotalidae polyvalent immune Fab (ovine). Ann Emerg Med (2002) 1.17
Asymmetric additions to dienes catalysed by a dithiophosphoric acid. Nature (2011) 1.17
Current status of interleukin-10 and regulatory T-cells in cancer. Curr Opin Oncol (2013) 1.17
Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression. J Biol Chem (2002) 1.15
A molecular dissection of the repression circuitry of Ikaros. J Biol Chem (2002) 1.14
Rapid evolution of disease resistance is accompanied by functional changes in gene expression in a wild bird. Proc Natl Acad Sci U S A (2011) 1.11
De novo production of dermal papilla cells during the anagen phase of the hair cycle. J Invest Dermatol (2010) 1.11
Awakening lineage potential by Ikaros-mediated transcriptional priming. Curr Opin Immunol (2010) 1.11
Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet (2011) 1.10
PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07
Enantioselective halocyclization using reagents tailored for chiral anion phase-transfer catalysis. J Am Chem Soc (2012) 1.07
A complex network of regulatory elements in Ikaros and their activity during hemo-lymphopoiesis. EMBO J (2003) 1.07
RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules. J Biol Chem (2008) 1.06
A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus. Cancer Res (2011) 1.04
β-Catenin induces T-cell transformation by promoting genomic instability. Proc Natl Acad Sci U S A (2013) 1.03